Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07235696

Game Intervention for Resilience

A Randomized Controlled Trial to Examine the Impact of a Game-based Intervention in Promoting Positive Affectivity and Enhancing Psychological Resilience

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
23 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if a game-based intervention can enhance psychological resilience and promote positive affectivity in adults who have experienced major life stress. The main questions it aims to answer are: * Does the game-based intervention improve positive affectivity and mental health compared to a waitlist control group immediately after the intervention and at 3-month follow-up? * Are the mental health benefits of the game-based intervention mediated by improvements in positive affectivity over time? Researchers will compare the game-based intervention to a waitlist control group to see if the game leads to better emotional and mental health outcomes. Participants will: * Be randomly assigned to either the game-based intervention group or the waitlist control group * Engage with the assigned program for 10 days within two weeks * Complete psychological assessments before and after the intervention, and again at 3-month follow-up

Conditions

Interventions

TypeNameDescription
BEHAVIORALGame-based InterventionThis intervention is a two-week game-based program designed to enhance psychological resilience and positive affectivity in individuals who have experienced major life stress. The game incorporates emotionally engaging features such as reward mechanisms, adaptive challenge levels, and implicit emotion-regulation cues. Unlike traditional psychoeducation or mindfulness-based interventions, this program uses interactive gameplay to target affective and cognitive processes associated with resilience.

Timeline

Start date
2025-05-19
Primary completion
2026-08-20
Completion
2026-12-20
First posted
2025-11-19
Last updated
2025-11-19

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT07235696. Inclusion in this directory is not an endorsement.